Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 40 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Stavropoulos, Konstantinos [Clear All Filters]
(2020).
Determinants of pulse wave velocity index and potential implementations..
J Clin Hypertens (Greenwich).
(2019). Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of RCTs..
Diabetes Res Clin Pract. 158, 107927.
(2019). Insomnia and hypertension: A misty landscape..
J Clin Hypertens (Greenwich). 21(6), 835-837.
(2019). Liraglutide as adjunct to insulin treatment in patients with type 1 diabetes: A systematic review and meta-analysis..
Curr Diabetes Rev.
(2019).
(2019).
(2019). Antihypertensive drug treatment: the real-life challenge..
J Clin Hypertens (Greenwich). 20(1), 115-117.
(2018). Carotid intima-media thickness as a target-organ damage and treatment-target: Need for a major revision?.
J Clin Hypertens (Greenwich). 20(2), 255-257.
(2018). Combination of SGLT-2 inhibitors and GLP-1 receptor agonists: potential benefits in surrogate and hard endpoints..
Curr Pharm Des.
(2018). Diabetes and lipid metabolism..
Hormones (Athens). 17(1), 61-67.
(2018). Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes..
N Engl J Med. 378(10), 967.
(2018). Peripheral arterial stiffness as a surrogate of central hemodynamics: A new era for cardiovascular risk estimation?.
J Clin Hypertens (Greenwich). 20(3), 469-471.
(2018). The potential role of statins in treating liver disease..
Expert Rev Gastroenterol Hepatol. 12(4), 331-339.
(2018). Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?.
J Clin Hypertens (Greenwich). 20(5), 942-948.
(2018). Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome..
Gynecol Endocrinol. 34(12), 1019-1021.
(2018). Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?.
Open Cardiovasc Med J. 12, 29-40.
(2018). Renal resistive index for renovascular hypertension: In the quest of the Holy Grail..
J Clin Hypertens (Greenwich). 20(3), 589-591.
(2018). Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?.
J Clin Hypertens (Greenwich). 20(4), 634-636.
(2018). Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension..
J Clin Hypertens (Greenwich). 20(1), 65-68.
(2018). Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 104-113.
(2018). Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease..
Cardiovasc Hematol Disord Drug Targets. 18(2), 120-126.
(2018). Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 83-85.
(2018). Subclinical target organ damage in primary aldosteronism: resistant to spironolactone therapy?.
J Hypertens. 36(3), 701.
(2018). What is the role of statins in the elderly population?.
Expert Rev Clin Pharmacol. 11(4), 329-331.
(2018).